Commentary to:A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growthJuho Suojanen, Tuula Salo, Erkki Koivunen, Timo Sorsa and Emma Pirilä
No takes yet. Share an insight, caveat, or question.
Zucker et al. (2009) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: